Literature DB >> 26421366

PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β.

Xuefei Zhang1, Xiaoqing Ren1, Qi Zhang1, Zheyi Li1, Shuaipeng Ma1, Jintao Bao1, Zeyang Li1, Xue Bai1, Liangjun Zheng1, Zhong Zhang1, Shujiang Shang2, Chen Zhang2, Chuangui Wang3, Liu Cao4, Qingsong Wang1, Jianguo Ji1.   

Abstract

AIMS: Parkinson's disease (PD) heavily affects humans and little is known about its cause and pathogenesis. Sirtuin 3 (Sirt3) plays a key role in regulating mitochondrial dysfunction, which is the main cause of DAergic neuronal loss in PD. We investigated the mechanisms of neuroprotective role of Sirt3 in DAergic neuronal survival.
RESULTS: Sirt3 was reduced in 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP)-treated neurons with its overexpression being neuroprotective. We identified that Sirt3 interacted with manganese superoxide dismutase (SOD2) and adenosine triphosphate (ATP) synthase β and modulated their activities by deacetylating SOD2 (K130) and ATP synthase β (K485) to prevent reactive oxygen species accumulation and ATP depletion, and to alleviate DAergic neuronal death upon MPTP treatment. Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) interacted with estrogen-related receptor alpha (ERRα) that bound to the Sirt3 promoter as its transcription factor to regulate Sirt3 expression and DAergic neuronal death. In the mouse midbrain, MPTP administration led to the loss of PGC-1α and Sirt3, high acetylation level of SOD2 and ATP synthase β, and the specific loss of DAergic neurons, while Sirt3 overexpression could protect against DAergic neuronal loss. Sirt3 knockout mice exhibited more sensitive and more DAergic neuronal loss to MPTP treatment. INNOVATION: The study provides new insights into a critical PGC-1α/ERRα-Sirt3 pathway, linking regulation of mitochondrial protein acetylation and DAergic neuronal death in PD pathogenesis, which provide a potential therapeutic strategy and target in PD treatment.
CONCLUSION: These results provide a vital PGC-1α/ERRα-Sirt3 pathway that protects against DAergic neuronal death by directly deacetylating SOD2 (K130) and ATP synthase β (K485) in PD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26421366      PMCID: PMC4761832          DOI: 10.1089/ars.2015.6403

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  60 in total

1.  PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.

Authors:  Joo-Ho Shin; Han Seok Ko; Hochul Kang; Yunjong Lee; Yun-Il Lee; Olga Pletinkova; Juan C Troconso; Valina L Dawson; Ted M Dawson
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

2.  The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons.

Authors:  Jeong Sook Kim-Han; Jo Ann Antenor-Dorsey; Karen L O'Malley
Journal:  J Neurosci       Date:  2011-05-11       Impact factor: 6.167

3.  Dynamic proteomic analysis of protein expression profiles in whole brain of Balb/C mice subjected to unpredictable chronic mild stress: implications for depressive disorders and future therapies.

Authors:  Yanyong Liu; Nan Yang; Wenyu Hao; Qing Zhao; Tianyi Ying; Shangyi Liu; Qing Li; Yan Liang; Tao Wang; Yilong Dong; Chao Ji; Pingping Zuo
Journal:  Neurochem Int       Date:  2011-02-22       Impact factor: 3.921

4.  SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient- and exercise-induced stress.

Authors:  Athanassios Vassilopoulos; J Daniel Pennington; Thorkell Andresson; David M Rees; Allen D Bosley; Ian M Fearnley; Amy Ham; Charles Robb Flynn; Salisha Hill; Kristie Lindsey Rose; Hyun-Seok Kim; Chu-Xia Deng; John E Walker; David Gius
Journal:  Antioxid Redox Signal       Date:  2014-03-06       Impact factor: 8.401

5.  SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; Lan Hua; Kristin E Dittenhafer-Reed; Bjoern Schwer; David B Lombard; Yu Li; Jakob Bunkenborg; Frederick W Alt; John M Denu; Matthew P Jacobson; Eric Verdin
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

6.  Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux.

Authors:  Qijun Wang; Yakun Zhang; Chen Yang; Hui Xiong; Yan Lin; Jun Yao; Hong Li; Lu Xie; Wei Zhao; Yufeng Yao; Zhi-Bin Ning; Rong Zeng; Yue Xiong; Kun-Liang Guan; Shimin Zhao; Guo-Ping Zhao
Journal:  Science       Date:  2010-02-19       Impact factor: 47.728

7.  Brain mitochondrial dysfunction in ovariectomized mice injected with D-galactose.

Authors:  Yang Su; Hao Sun; Jie Fang; Gang Hu; Ming Xiao
Journal:  Neurochem Res       Date:  2009-09-24       Impact factor: 3.996

Review 8.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Inhibition of platelet aggregation by 1-methyl-4-phenyl pyridinium ion (MPP+) through ATP depletion: Evidence for the reduced platelet activities in Parkinson's disease.

Authors:  Kyung-Min Lim; Hyun-Hee Kim; Ok-Nam Bae; Ji-Yoon Noh; Keun-Young Kim; Sae-Hwan Kim; Seung-Min Chung; Sue Shin; Hyeon-Yeong Kim; Jin-Ho Chung
Journal:  Platelets       Date:  2009-05       Impact factor: 3.862

10.  The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase.

Authors:  Bjorn Schwer; Brian J North; Roy A Frye; Melanie Ott; Eric Verdin
Journal:  J Cell Biol       Date:  2002-08-19       Impact factor: 10.539

View more
  29 in total

1.  Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.

Authors:  Guoliang Meng; Jieqiong Liu; Shangmin Liu; Qiuyi Song; Lulu Liu; Liping Xie; Yi Han; Yong Ji
Journal:  Br J Pharmacol       Date:  2017-07-06       Impact factor: 8.739

Review 2.  Mitochondrial pathways to cardiac recovery: TFAM.

Authors:  George H Kunkel; Pankaj Chaturvedi; Suresh C Tyagi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 3.  Intermittent metabolic switching, neuroplasticity and brain health.

Authors:  Mark P Mattson; Keelin Moehl; Nathaniel Ghena; Maggie Schmaedick; Aiwu Cheng
Journal:  Nat Rev Neurosci       Date:  2018-01-11       Impact factor: 34.870

4.  Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress.

Authors:  Han Shi; Han-Xiang Deng; David Gius; Paul T Schumacker; D James Surmeier; Yong-Chao Ma
Journal:  Hum Mol Genet       Date:  2017-05-15       Impact factor: 6.150

Review 5.  Role of PGC-1α in Mitochondrial Quality Control in Neurodegenerative Diseases.

Authors:  Qi Zhang; Yu-Hong Lei; Jue-Pu Zhou; Ye-Ye Hou; Zheng Wan; Hong-Lei Wang; Hao Meng
Journal:  Neurochem Res       Date:  2019-08-13       Impact factor: 3.996

6.  Microglia activation induces oxidative injury and decreases SIRT3 expression in dopaminergic neuronal cells.

Authors:  De-Qi Jiang; Yan-Jiao Ma; Yong Wang; Hai-Xiao Lu; Shu-Hui Mao; Shi-Hua Zhao
Journal:  J Neural Transm (Vienna)       Date:  2019-04-19       Impact factor: 3.575

7.  SZC-6, a small-molecule activator of SIRT3, attenuates cardiac hypertrophy in mice.

Authors:  Ze-Yu Li; Guo-Qing Lu; Jing Lu; Pan-Xia Wang; Xiao-Lei Zhang; Yong Zou; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2022-08-30       Impact factor: 7.169

8.  Hydrogen Sulfide and the Kidney.

Authors:  Balakuntalam S Kasinath; Hak Joo Lee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  The Protective Effects of Mogroside V Against Neuronal Damages by Attenuating Mitochondrial Dysfunction via Upregulating Sirtuin3.

Authors:  Hanjiang Luo; Caixia Peng; Xiaofeng Xu; Yuntao Peng; Fang Shi; Qinghua Li; Jianghui Dong; Min Chen
Journal:  Mol Neurobiol       Date:  2022-01-18       Impact factor: 5.590

10.  Sirtuin 3 deficiency exacerbates age-related periodontal disease.

Authors:  Junsheng Chen; Yarong Zhang; Jing Gao; Tao Li; Xueqi Gan; Haiyang Yu
Journal:  J Periodontal Res       Date:  2021-09-30       Impact factor: 3.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.